I re-read and find some of this verbiage from the Q2 financial informative as it relates to the road ahead. Nothing new here, discussing previous news.

The Company’s focus is on developing and acquiring businesses and products for health-related industries as alternatives to toxic pharmaceuticals. In that pursuit, the Company has been creating new and innovative products, cultivating distribution arrangements and manufacturing resources. In addition, the Company has acquired and intends to build schools with a focus on Autism. Able Academics will be a focus of new schools and nutraceutical and stem cell alternatives for these afflicted individuals.

Additionally, the company has entered into joint venture relationships with Able Academics Schools and Stemspa.

Additionally, for its products, it has formulated several outstanding distribution networks to include alternatives for physicians to offer our products to their patients as alternative to prescription and often toxic drugs.

Principal Products
The Company’s principal products have been formulated and produced. Our initial products focus on specific illnesses common to the mass market. Rare cannabinoids have been harnessed and used in sufficient quantity and in appropriate combinations to render efficacy: Relief Raspberry gummies, Calming Mango and Sleepy Watermelon have key formulations with an obvious purpose suggested in the name. These formulations are unique to the market and have been internally tested for efficacy. Furthermore, their safety is such that multiple gummies can be consumed without issues. These products were designed to work with our nutraceuticals, which alternatively have no CBD in their formulations. These nutraceutical compounds are produced after extensive Research and Development: Inflammaplex, EnergyPlex, and Painplex have amazing preliminary results in our internal anecdotal testing and work in conjunction with our gummies to relieve the issues internally.

Stem Cells is our latest acquisition. We have specific algorithms for appropriation and administration that we are delivering currently and will be presenting to the mass market shortly. We will be focusing on brick-and-mortar clinics, rendering stem cells to the lay physician and possibly developing off-shore locations for the administration of
these mostly umbilical-based products.

Distribution and Marketing
We have developed multiple channels of marketing and are not limiting our efforts to the United States alone, but have eyes on Mexico, Canada and South America as well as the surrounding Island nations. Our marketing will channel physicians, internet and retail facilities. We have teamed up with Virexit to initiate a novel internet marketing campaign that will essentially be a word-of-mouth campaign in digital format. We are currently working on more avenues of distribution and celebrity endorsements.

New Products - The specific products will not be named until they have been trademarked. Fortunately, we now have a facility for their creation. Eden Labs has been astounding in the attention to detail for the first formulations. They were charged with ethanol extraction of the proper portion of appropriate herbs in order to harness the most effective chemicals. This, in turn was reduced to powder after concentrating and placed into capsules. These formulations are expensive, but effective because of the chemistry behind them and the years of clinical knowledge that went into the creation. Our future formulations will be addressing: autism, memory, aging, chronic sleep
issues, libido and more. With anticipated funding, we look forward to completing the research and development of these products and mass produce them by the end of 2022.

Competitive Business Conditions
While our formulations cannot truly be protected, we have distinct advantages to the market from being the first out with our targeted products. Our nutraceuticals are being produced after over 20 companies were vetted and only one was able to produce them. Eden is under a non-disclosure agreement for our products. Unlike other nutraceuticals on the market, ours are formulated to have an instant effect without side-effects. Our Energyplex, for example, gives a noticeable burst of energy and focus without caffeine or sugar. Our Painplex formulation, works on other pathways than our Raspberry Relief gummy, so that the overall effect is very competitive to the opioid market for relief of discomfort.

Link to Financials - https://www.otcmarkets.com/otcapi/company/financial-report/298782/content

Few things to note that I noticed...
Monique Todd (Able) was given 30m shares in March 2020. Now they have moved to Cocoa, and opened up a clinic in Daytona and Tutoring in CA. Updated website with more personnel. After all, revenues from this arrangement are being presented on the financials, yet GRPS hasnt provided the funding yet.
https://ableacademics.com/

Info on the StemSpa front is quiet, but according to the financial notes above it is being worked on. Artin Babayan "purchased" 12.5m shares at .001 in March 2020. He is a real estate broker and loan officer in CA. Maybe he is helping find locations.

Not sure if this has been posted here yet, but saw StemSpa, Inc. is filed August 4th.
https://search.sunbiz.org/Inquiry/CorporationSearch/SearchResultDetail?inquirytype=EntityName&directionType=Initial&searchNameOrder=STEMSPA%20P210000703990&aggregateId=domp-p21000070399-7f506c25-b4c9-424a-8229-6ef3a3800c32&searchTerm=Stemspa%2C%20Inc.&listNameOrder=STEMSPA%20P210000703990

https://search.sunbiz.org/Inquiry/CorporationSearch/ConvertTiffToPDF?storagePath=COR%5C2021%5C0805%5C30116603.tif&documentNumber=P21000070399

If you take a look at Berkowitz' previous company, PacificStemCells, the website is no longer up. They got a letter from FDA about their marketing. On Berkowitz linked in, you can see his employment for PSC goes to August 2021.
http://pacificstemcells.com/
February+17,+2021+Untitled+Letter+-+Pacific+Stem+Cells+LLC.pdf
https://www.linkedin.com/in/mike-berkowitz-2354536/

On August 9, Dr. Bond tweeted this pic of RG presenting in front of Pacific Stem Cells presentation.
https://twitter.com/DrBruceBond/status/1424751557762064385



Lots coming down the pipeline between now and the end of 2022. Hold for Gold. Hold for paper.

Quarter 3 financials should be posted to OTC on or before 11/14.

$GRPS

That would be incredible, and is an excellent idea. This here is another opportunity for the ceo to do something significant for shareholders - not necessarily unprecedented in OTC like the whole split off thing would have been, and not unprecedented because many companies have done buy backs - but it would be significant because of this stock's following and money invested here. Its what everyone is asking for. Of course we don't want a reverse split. I don't think the Reg A investor would invest if a reverse split a consideration. He would benefit the same as existing shareholders if there was a reduction in half used by his funds.

Lets Do it $RSHN

I searched google for "Gold River Productions" and click tools and you can select how far back to look. I usually look within the last week. One of my favorite ways to find new DD.

I too think Goulding and Bond are doing awesome with the interviews and videos. All I was meaning to say is the interviewer could be more knowledgeable about what they are asking.

I believe this a new podcast I found. It is not the Slight Edge.

Very informative!!

https://player.fm/series/success-insight/dr-richard-goulding-physician-surgeon-and-chairman-chief-medical-officer-at-gold-river-productions-inc-a-medical-nutraceutical-company

Since medical doctors stick to the pharmacological side of things and issue big pharma painkillers, GRPS products are going to be products that empower other medical practitioners like therapists, chiropractors, personal trainers, etc, etc, any medical practitioner or doctors who don’t bow down to big pharma will recommend GRPS products.

Where do they find these interviewers? They can’t speak for crap.

Happy Halloween GRPS!

New Tweet:
10/19/21, 11:12 AM
H.R.4350 - 117th Congress (2021-2022): National Defense Authorization Act for Fiscal Year 2022 | http://Congress.gov | Library of C...
H.R.4350 - National Defense Authorization Act for Fiscal Year 2022. This just passed the house. Now senate!

 10/19/21, 11:12 AM H.R.4350 - 117th Congress (2021-2022): National Defense Authorization Act for Fiscal Year 2022 | https://t.co/SlFIur2gdm | Library of C...
H.R.4350 - National Defense Authorization Act for Fiscal Year 2022. This just passed the house. Now senate!

— @grpsinc (@grpsinc) October 29, 2021

Good morning, and happy Friday. $GRPS

I am not saying anything. I have never told anyone to buy, add, or sell here. I always state facts and opinions only.

For discussion purposes, I have enough shares. I'm not averaging down on a falling knife. There are a lot of new people here since the run to .0249, so obviously for them it may be a good time to average down. For me, I've been here since 2018, so I am not in a good mood about buying more again until I see more buying pressure. I have shares at all different prices here.

The accumulation/distribution line keeps going down, and there is obiously no massive volume or bid support. Its not like it was before the run, when accumulation was only going up. Things are different at this point. Such a bummmer. The distribution line is so drastic downward, it tends to line up with how someone mentioned once that someone allegedly bought 4 billion shares, and obviously has and continues to slowly sold them all off. Who the hell sells anything below .005 here? Someone who is still making profit obviously.

As for the down trend, this is what happens when companies say one thing, and then change course completely. We were all juiced up on divies and sweeteners, and now nothing. I don't blame people for getting pissed, but at the same time, this is like the 3rd time this stock has gone through this. Its not for the faint of heart, for sure, and a lot of new people are experiencing this for the first time. This is the 3rd time for many ultra longs. Hopefully the 4rd quarter financials help stop the bleeding.

D

Gold River Productions, Inc. / OTC: GRPS
Information Compilation

Dedicated to changing people’s lives, Gold River is a groundbreaking company aiming at improving quality of life and longevity. Our diverse products and interests include nutraceuticals, CBD, land, education and now Stem Cells. With a unique staff of physicians, cultivators, and CBD experts, we are poised to tackle different disease states on an unprecedented level. Utilizing years of experience in herbals, rare cannabinoids, traditional and non-traditional methods of patient care, we are in the unique position to utilize CBD and herbals in the most effective ways possible and make stem cells a widely accepted entity that will benefit thousands. Emphasis on what already works, then augmenting effective formulas with high-quality cannabinoids in therapeutic levels can achieve unprecedented symptom control in a myriad of disease states.

Company Officers
Dr. Richard Goulding, MD, Chairman
Sam Elias, Chief Revenue Officer
Dr. Bruce Bond, DC, DCABN
Dr. Jackie Bond
Dr. Danielle Morosco, Veterinarian
Michael Berkowitz, Stem Cell expert
Frank DeAngelo (possibly in the background-imo)

Stock Info
Pink Current / Verified Profile
1,300,000,000 Authorized
1,277,089,842 Outstanding Shares (Restricted: 222,198,093 / Unrestricted 1,054,891,749)
896,746,739 - Float as of 06/30/2021
OTC disclosures & Financials: https://www.otcmarkets.com/stock/GRPS/disclosure

No Reverse Split & No Toxic Lending Risk
On 2/28/21, the company updated its articles to include this note regarding toxic debt and no reverse stock split:

“The Corporation shall not issue any convertible promissory notes, convertible preferred stock or
other convertible instruments. The Corporation shall not engage in a reverse stock split.”
https://www.sos.state.co.us/biz/ViewImage.do?masterFileId=20181590379&fileId=20211208704

Website: https://www.grpsinc.com/
Twitter: https://twitter.com/grpsinc
https://twitter.com/DrBruceBond
^^Lets get the company some more followers!

Contact Info
Gold River Productions, Inc.

Main Office:
1419 Chafee Dr., Suite 3
Titusville, FL 32780

Other Location noted on product packaging:
4 Office Park Drive
Palm Coast, FL 32137

info@grpsinc.com
richardgoulding@grpsinc.com

Company Video - Must Watch
https://www.youtube.com/watch?v=l5jg5Xvjf1o

Products Available for Pre-Order
https://doctorbondsgummies.com/
*please note that this is a pre-order as noted on the page..

Everywhere you should be able to get the products:
https://doctorbondsgummies.com/
https://saferplace.market/
https://saferplace.market/search?q=gummies
www.vmarket.shop
http://vividcbd.com
https://www.allstarhealthbrands.com/shop/

Company Trademarks & Applications
https://uspto.report/company/Grps

Quarterly Podcast with the Slight Edge

Episode 1: https://podcastpeteslight.podbean.com/e/the-slight-edge-grps-001/

Episode 2: https://podcastpeteslight.podbean.com/e/the-slight-edge-grps-002/

https://www.grpsinc.com/grps-podcast/ - The GRPS website has a field to submit topics for them to cover in next quarter’s podcast.

On August 20th, the company posted this video on their Youtube Channgel. Take a look.
MD vs. Chiropracter. Dr. Richard Goulding & Dr. Bruce Bond
https://www.youtube.com/watch?v=iFFrLStY00M

Notes from the most recent financial disclosures:
NOTE 3 - INVESTMENTS AND JOINT VENTURES The Company uses the term inputs for the valuation of joint ventures and investments. The Company intends to hold investments for a term longer than one year. The Company’s investments are not traded regularly on open markets and the valuation can be very subjective. For the years ended December 31, 2020 and 2019, the Company viewed all investments as Level 3 investments with an ending value of $516,250 and $70,750, respectively. The values remain the same at March 31, 2021.

NOTE 10 - STRATEGIC ALLIANCES During 2019, the Company entered into a strategic alliance with LeGanjaFairy LLC (LeGanja) and RushNet Inc. (Rush). As part of this alliance, LeGanja will be provided $5,000,000 in funding in exchange for their gross revenues from operations being assigned to an escrow account. Those gross revenues, less a variable percentage, will belong to the Company and paid out according to the agreement with LaGanja and RushNet Inc. During the year ended December 31, 2020 LaGanja failed to provide financial statements in accordance with the strategic agreement for the 3rd and 4th quarters. At this time, the Company is evaluating whether or not to continue with the agreement.

During 2020, the Company entered into a strategic alliance with Able Academics LLC (Able). As part of this alliance, Able will be provided $7,500,000 in funding in exchange for their gross revenues from operations being assigned to an escrow account. Those gross revenues, less a variable percentage, will belong to the Company and paid out according to the agreement with Able. During the three months ended March 31, 2020 those revenues totaled $868,871.

https://www.otcmarkets.com/otcapi/company/financial-report/298782/content

Here is a Rundown of Recent Product Development News & Company Updates
**All of this information is pulled from their Twitter Feed or PRs

May 23 - Company offers a look-ahead, and notes minor issues with Shopify.
In the next few weeks we will be excited to reveal a lot of the details regarding partnerships, doctor networks, crucial affiliates. Shopify is being addressed. Many companies have Cbd policies that are difficult to navigate properly. We have hired a terrific marketing firm.

June 1 - Company asks for patience
We are entering a phase of our operations that will demand a significant amount of extra time and attention. Although our social media updates will be reduced, we appreciate your patience as we work to finalize agreements that we believe will bring great value to our organization

June 16 - Announced contract with Eden Labs for Painplex, Energyplex, & Inflammaplex
We are committed to quality, which is why we contracted with the best in the business—Eden Labs to help make PAINPLEX, ENERGYPLEX, and INFLAMMAPLEX a reality. What's unique about Eden is their ability to extract properly (ethanol extraction at specific ratios).

https://www.edenlabs.com/

June 16 - Announced contract with HoliHemp in Washington State to produce the gummies line of products
Holihemp, in WA, was contracted to make our gummies due to their broad range of applications and a reputation for using Compliant Hemp Oil Distillate. Their ability to insert large quantities of rare cannabinoids in gummies without sacrificing taste was key. They operate a stellar facility that meets state, fed, and intl regulatory standards.

https://www.holihemp.com/

June 17th - Announced their partnership with Laurelcrest CBD for CBD source
We'd like to share with you our first class source for product. LAURELCREST. They were able to institute our precise targeted formulations utilizing large amounts of specific and rare cannabinoids.

https://www.laurelcrest.com/

LAURELCREST offers us:
- Advanced Delivery Systems
- USA Grown Hemp
- Allergen-free
- Full Spectrum/Broad Spectrum
- Isolates
- Consistent High Quality
- Full Traceability
- Control from Seed to Sale
- NANO Technology
- 100% Regulatory Compliance

June 21 - New logo and announcement of a marketing team hired
Innovative products and solutions are the foundation for growth, but innovation by itself cannot sustain an organization; it must be coupled with strategic marketing. We're pleased to share that we've retained a marketing team with limitless capabilities. https://twitter.com/grpsinc/status/1406997126362578952

June 21 - Company telling us that there will be steady news, once ready...
We have mapped out a progressive release of information and will continue to reveal marketing, acquisitions and what the future holds. This will not happen all at once, and there’s a lot of information that will become clear

June 23 - Company News Release - Distribution through AllStar Health Brands to commence internationally
Gold River Productions (OTC Pink: GRPS), through its distribution partner, All Star Health Brands Inc, expects to commence distribution and sales of three of its unique-formulated supplements as well as the first set of products within its long-awaited gummy line. This distribution will expand to certain international markets within the next six months. Ongoing discussions are in place with Jamaican and US distributors. Other markets may include Canada and parts of Latin America. Also noted is a source of funding from a charity. http://epidemiologicsolutions.com/
https://www.otcmarkets.com/stock/GRPS/news/Gold-River-Productions-GRPS-announces-distribution-plans-and-finalization-of-RD-for-three-unique-formulation-supplements?id=308673

June 25 - Company provides operational updates via twitter
As our loyal shareholders know, we are very diligent in the quality of our personnel and our products. We are taking special care to ensure the best partners for distribution as well, as that’s the key to our future. This must be a solid acquisition and not done in haste.

In the last year, we have done some very remarkable things as a company:

We have created and produced core products that are unique to the marketplace and sorely needed by customers

We have demonstrated the unique efficacy of three of these products (our gummy line), as shown in many enthusiastic testimonials

We have initiated 2 different distribution models with wide ranging potential and are now getting ready to deliver those products

We have amassed a professional staff of dedicated, highly respected physicians and business people that share our enthusiasm for the company mission

We have engaged a dedicated marketing firm that specifically sought us out because of the effect our product had on a family member

All of this has been done so far on personal funding with no dilution. The future is ours, and we wish to thank our family of investors for their patience. With all the pieces falling into place, now the fun can really begin.

July 14 - GRPS names Dr. Danielle Morosco to the team, and creates a Pet Division.
Gold River Productions, Inc. (OTC Pink: GRPS) expands its product line into the pet space, an industry with a projected market size of $325,740,000,000 by 2028, according to Fortune Business Insights. We welcome our newest member, Dr. Danielle Morosco, to head our veterinary division. Dr. Morosco has vast experience with domestic animals, especially cats and dogs, and has enthusiastically embraced our unique formulation for pain and anxiety for house pets. Her expertise also includes treating larger animals. We are impressed with her input designing an equine and bovine formulation based on our pain formula.
Dr. Morosco graduated with honors from Ross University School of Veterinary Medicine, focusing on emergent and animal chronic care. She is currently completing a 110-hour continuing education course to become a Veterinary Botanical Medicine Consultant, which includes in depth modules about herbal treatments and CBD in veterinary patients.

“Our pet formulation appears to be the only one on the market that utilizes rare cannabinoids in addition to being affordable and effective” says Richard Goulding, M.D. “And when it comes to how pets are viewed by their owners, they are essentially people too. Their problems are more subtle and it’s often difficult to gauge when an animal is in pain. But the dogs we’ve tested with this product, we’ve seen noticeable and immediate results and a real sense of calm.”

https://www.otcmarkets.com/stock/GRPS/news/Gold-River-Productions-Inc-GRPS-Announces-its-Veterinary-Division-Headed-by-Dr-Danielle-Morosco?id=311570.

Obviously, Dr. Morosco is highly qualified in Pet CBD. Take a look at this website that she already has in place.
https://thedogtordani.com/

July 28 - Dr. Bruce Bond posts photos of samples of the Plex Line on twitter
Received 650-700 capsules of each product from EdenLabs Energyplex, Inflammaplex, Painplex and Echinaceaplex. Want to thank Dr. Goulding and the whole GRPS team for all that they are doing. We will be working on the next phase which is developing labeling, etc. and then go to larger production and then bottling.

https://twitter.com/DrBruceBond/status/1420488965564604422

August 4 - GRPS names Michael Berkowitz to the team, creates StemSpa Subsidiary and Rejuvenation Division
“We are in negotiations to construct stand-alone facilities in strategic locations to establish “StemSpa,” which will serve as centers of excellence in the United States and offshore. We will begin with approximately 1000 doctors thanks to the relationship built between GRPS, heliosDx, and CEO Ashley Sweat of Rushnet (OTC Pink: RSHN).
https://www.globenewswire.com/news-release/2021/08/04/2274718/0/en/Gold-River-Productions-Inc-GRPS-Appoints-Michael-Berkowitz-to-spearhead-the-Rejuvenation-Division-with-StemSpa.html

August 9 - Gold River Productions, Inc. (GRPS) signs agreement for marketing and distribution with VirExit Technologies

https://saferplace.market/
https://saferplace.market/search?q=gummies

Gold River Productions, Inc. (OTC Pink: GRPS) announced today the finalization of a marketing and distribution agreement with Virexit Technologies.

“VirExit Technologies (OTC Pink: VXIT) is not just another marketing website,” says Richard Goulding, M.D., Chairman of the Board of Gold River Productions. “The Safer Place Market (www.saferplace.market) which is transitioning into the VMarket (www.vmarket.shop) is truly a unique concept that marries ‘word of mouth’ advertising with viral marketing. Their concept is fascinating. It enables the linking of actual consumer and business experiences to multiple internet outlets. The company’s focus on wellness, health, productivity, and safety offers real solutions for businesses and consumers.

Every product in VirExit’s stores is curated and focused directly on these four pillars. The public is inundated with ads, glitzy marketing and celebrity endorsements. Understanding what one finds online and the value of it is challenging. Finding a best of breed product, with a foundation in science and medicine, is challenging.
VirExit and Gold River Productions are achieving this level of product credibility. Announcing game-changing products, including our gummy and nutraceutical lines is both exciting and energizing. Now that research and development have been completed on Inflammaplex, Painplex and Energyplex and we’ve had a chance to sample the outstanding technical work of Eden Labs, we’re moving into mass market availability of these products.

https://www.globenewswire.com/news-release/2021/08/09/2277152/0/en/Gold-River-Productions-Inc-GRPS-signs-agreement-for-marketing-and-distribution-with-VirExit-Technologies.html


August 19 - AllStar Health announces implementation of distribution and sales of Gold River Products beginning with their “Dr. Bond’s Gummy Line”

“The wait is over,” explains Pete Wanner, CEO of AllStar. “We are excited about the launch of Gold River’s products and to be the first in line to purchase GRPS products. We have a number of distributors anxiously awaiting their products, Dr. Bond’s Gummy line: Sleepy Watermelon, Relief Raspberry and Calming Mango.”

This is a game changer for the CBD industry. Gold River has created a high-grade formulation that targets specific consumer issues. We have not seen any formulations like this. We’ve tried them, tested them, sampled them and the results are very supportive. This isn’t your average CBD gummy. Not by a long shot. Our initial distribution will be in Jamaica and Florida. Now that we have product, we will be engaging in larger distribution channels including the United States, Mexico, Canada as well as the adjacent Islands. What intrigues us most about Gold River is their product line, which is unique, high end and in our opinion, a fresh and new in the nutraceutical world. It will set the gold standard. They did it right, and their video is spot on.

“We will be marketing online as well through http://vividcbd.com and the AllStar Website.”

August 27th - GRPS pre-orders for three gummy products are shipped
The long wait is over! Pre-orders are going in the mail, and the website will be accepting regular purchase orders soon. Can’t wait to add your reviews to all the amazing ones we already have!

September 21-October 9th - Company Tweets Out Various Updates
“We will be conferencing with one of the largest distributors in South America There are logistics issues with Mexico and South America due to Cbd quirky laws but I feel confident we will get it done.”

“On another front, we have shared our pet formulation after NDA’s signed with a group out west that has great ties in Mexico as well. They are now doing R & D on the biscuits with the specs required. This isn’t simple as several of the cannabinoids are quite heat sensitive. Dr Morosco has adjusted the formulation to include components for inflammation as well, so that the biscuits will have more utility and aren’t for “as needed” use. They will be daily.”

“Lots happening. Huge month for us on many fronts:
1) We should have answers by month’s end on a number of government opportunities including a new initiative, which we have targeted. More on this very soon
2) We have reached a final and very favorable price with Eden Labs on Inflammaplex, Painplex and Energyplex. We are stunned by the efficacy of these three products, especially in combination with the gummies. Our target for bottled product is the first of the year. All Star will release this week new website for the gummies - meeting tomorrow with professional sports team - very excited about the product combinations for their athletes.”

3) “Our platform for doctors and chiropractors with processing is being tested and is about ready to go, but we would like all six (+) products available before the launch. Look for two new podcasts we have created to come out shortly.”

4) “Thanks for your patience. We are excited to move to the revenue/distribution phase!”

September 30th - Website Getting Updates

“Our website is undergoing updates! Excited, more than ever, for our path forward! We are just getting started on this trail that we've blazed. We continue to be humbled by our fantastic team and our loyal shareholders who have made this next phase (revenue) possible.”

October 9th - Website Ready To Go for Next Week

“We have completed all of the planned updates to our website. We are now waiting on third party underwriting to give us the green light for the final piece. Should be Monday or Tuesday. Stay tuned!”

YTD Chart Showing Accumulation
Link to Chart

Go $GRPS !! Time to show everyone the goods !

-D-Money6

I noticed it was at zero this morning. Around 2pm, it reset to end on Tuesday around 9am. I would imagine an updated website......

Looks like they’re now shooting for Tuesday morning around 9 with the timer on the website. So much in the pipeline with the plex line of products and the pet products. Can’t wait to see what they add to the website. It’s only a matter of time before there is news and after news, and that will soon include revenue.
https://www.grpsinc.com/

Accumulation has been constant, even right through, what was appears to be, only a test of .04. As you can see, there was no dip in distribution after that point, and fairly steady price since. Most of that accumulation this year in the .01 area. Almsot all shares that have been added are restricted, so very little dilution.

Link to YTD GRPS accumulation

Thank you. Going well. Still here. As many know I'm in GRPS too. They released a podcast today. Based on what was in that, I think we might see some news soon regarding a collaboration with them for a network of 1,000 doctors Network to make their nutraceutical products and StemSpa services available to.

"....We will begin with approximately 1000 doctors thanks to the relationship built between GRPS, heliosDx, and CEO Ashley Sweat of Rushnet (OTC Pink: RSHN). I’m very excited to have doctors in this continuously expanding group utilize our inflammatory-reducing product line and have our technology at their fingertips. This will offer an amazing alternative to their patients as well as help us develop broad data collection and deliver data that these biologics are not only effective, but in the right hands and with the right techniques, possess endless possibilities to those suffering.”

https://www.otcmarkets.com/stock/RSHN/news/Gold-River-Productions-Inc-GRPS-Appoints-Michael-Berkowitz-to-spearhead-the-Rejuvenation-Division-with-StemSpa?id=314781

I think companies in the OTC were affected a lot with the pandemic. I think they are all rearing to go to close out this year. At least that would be very nice, and hope that for all of us.

Not to mention the numerous amount of times he said we'll have updates and answers at the end of the month.

To me, it sounded like there are already govt contracts, where they are fulfilling product for review and consideration, and then we wait for answers on the govt proceeding to get involved with more POs.

The tips and forecasting of things to come in that podcast give me the chills of where this could go into the new year.

Nice! ...regarding the billboards. I have been noticing NewToTheStreet has been posting on twitter the live times square billboards for the companies who recently did interviews with them. I was wondering when RSHN's billboards would be live.


$RSHN

Never thought we’d get a news release with the serial diluter Fartman. Can’t stand any association with them.

My order # was 1021 on 4/28.

Never got any anything after that, but did receive them on Saturday. If you have your email confirmation, I would send it to Mr. Goulding's email. I'm sure he will check into it.


from: Gold River Productions <richardgoulding@grpsinc.com> via shopifyemail.com

Gold River Productions
ORDER #1021
Thank you for your purchase!
Hi D, we're getting your order ready to be shipped. We will notify you when it has been sent.


If you have any questions, reply to this email or contact us at richardgoulding@grpsinc.com

With the new wording "term sheet" (a non-binding preliminary agreement), the $20m funding is not necessarily going to be done through a Reg A offering, where shares would be added/diluted. Therefore, it is hopeful that this is a preferred share situation (the funder gets ownership equity) and potentially annual dividends), and that zero shares will be added to the common shares.

There is no way they would add any amount of shares to common at this point, and the person funding them would not do it if there was any potential for R/S.

We must wait and see the details about the funding.

I tried 1 calming mango last night around 7pm. Problem is I drink beer and smoke cannabis too. Its hard to tell if anything was felt differently. I went to bed around 12am, slept pretty good. I will probably try to find a time to take 2-3 without anything else. My girl, step daughter, and her boyfriend all ate one calming last night. Like I said, tough to tell off one, I guess. We'll see. It will take a while to try them all.

I like how it tastes slightly like a medical supplement. Its not sweet or sugary. It tastes like its a medicine and, if it works for more than not, it will be awesome.

Received my pre-orders today too! Packaging is really nice.

The company is promoting HeliosDX on a national campaign, with commercials, yet if someone was to look up what state the company is registered they would not find anything unless they knew it was CPLS who has yet to officially change their name.

From a PR 7/15:
The company recently finished its Phase One rebranding strategy from Chattahoochee Labs to heliosDX. The company is preparing to launch a national sales campaign in the coming weeks to further its already rapidly increasing footprint. The campaign is designed to accomplish two goals. The first goal is to grow our sales reach and gain incremental new business across the country. The second goal is to utilize the national sales campaign as a mechanism of pushing the heliosDX brand further, in what we are calling Phase Two.

At what phase does the CPLS file an amendment to change its name? That's all I am asking.

It is kind of important. I own a couple of businesses myself, and if I had a business with a name I filed, but one day started calling my business something different and I have not filed an amendment or a DBA, that would be unprofessional.

Does anyone know if and when Chattahoochee Physicians Laboratory Services is going to be changing their name with the GA sos to HeliosDX? At this moment, there is technically no HeliosDX.

Just had another thought...the ex-divy date catalyst that everyone wanted to wait for buying HeliosDX is no longer in the future. HeliosDX is in RSHN already so I don't know why people were waiting for the divy date in he first place.

People that have been here have already been through two reverse split fake outs and now a stock dividend fake out basically. We're very lucky this is not down significantly more. Last thing we need is any reverse split discussion, no matter how small.

(smell, speaking in general, not replying to you specifically)


Result of this news that everyone hounded the CEO for...

No more stock dividend (free shares) of HeliosDX
No more ability to buy discounted shares of HeliosDX
No more sweetener (additional free shares) for buying the discount
No more guarantee of ending up with 3 separate stocks. Now we must wait to hear if any one or more will be split off in the future.
No more share conversion to reduce the RSHN share structure, resulting in no current guidance on reducing RSHN share structure. (before today, we at least knew there some plan and it would be up to shareholders to execute it.
No more offering to raise money. If RSHN dually lists on the TSXV it may raise funds, but no more US offering. We must try to uplist from OTC as RSHN.

Before todays News

RushNet, Inc. (Original Company)
HeliosDX (As of July 1 under RSHN) (was under RSHN going to be split off)
Grandeza Healthecare (As of August 22)

After todays News
RushNet, Inc. (Original Company)
HeliosDX (As of July 1 under RSHN)
Grandeza Healthecare (As of August 22)

Tell me again how this adds value to RSHN?? We were told we were going to get stock dividends.

Many here thought RSHN would be more valuable remaining as one company with subsidiaries. Why? Now that we got that news, does it not make anyone realize that we already had all subsidiaries under RSHN for many weeks now?

There was weeks and weeks of progression here building up on the spin-off idea (free shares, discounted shares, then a sweetener, etc) and now all of that has gone by the wayside. Very disappointing development, to me anyways.

Looking forward to the announcement on how much the purchase orders are from both All Star Health and Virexit. Both, I believe, buy the products up front and sell on their website. It will be nice if we get an estimate on how many units are being sold that we can track anticipated revenue.

It looks like the share counts at the very top of the document and also on the 2nd page were not updated to reflect 2nd quarter. The initial filing for 2nd quarter had the 1st qtr share counts in those spots.

Should be back to current early next week...However I am perplexed that they allow such silly mistakes.

Things will slowly start to fall into place. Many more catalysts here through 2022 as RushNet grows their operation.


RushNet, Inc. RSHN (The primary stock)

HeliosDX (to be split off, RSHNers will receive a 2nd stock and benefits as previously PRed)
-$10m acquisition on the way by end of year that will be under HeliosDX.
-Toronto Stock Exchange Listing
-Form 1-A Offering

RushNet legacy CBD (to be split off, you will receive a 3rd stock)
-Who knows what we will get

Grandeza Healthcare (will remain under the Holding company RushNet, Inc. RSHN)
-Share reduction will take place via share conversion to HeliosDX.
-In the coming months, Grandeza expects rapid growth as it intends to add a department within the company focused on temporary healthcare employment.

Future acquisitions may or may not be split off as mentioned in the interview, and will likely fall under the RushNet, Inc. holding company. (more possible stock dividends and/or value for RSHN).

GRPS MD Vs Chiropractor

I know that Helios' 2nd qtr numbers were posted under research, but are we supposed to have something posted under disclosure for 2nd qtr financials? No late notice either.

New Earth Development Corp. re-activated with Colorado SOS.

Thank you Dr. Rick for a great weekend in Orlando and bringing together great speakers to educate doctors on how to make a difference in the lives of others.
https://twitter.com/DrBruceBond/status/1424751557762064385


Now to go down the Pacific Stem Cells rabbit hole...


Pacific Stem Cells, LLC was acquired by DFCO's subsidiary in February 2021.
https://www.prnewswire.com/news-releases/dalrada-financial-corporation-completes-acquisition-of-pacific-stem-cells-llc-301222079.html

Pacific Stem Cells website is parked.
http://www.pacificstemcells.com/

Pacific Stem Cells Videos
https://vimeo.com/channels/pacificstemcellsfilms

It is possible that that StemSpa may be another version of what Pacific Stem Cells did, but here RG is in front of a slide that says Pacific Stem Cells, so just wondering if anyone else has any suggestions

Gold River Productions, Inc. Information Pack

Dedicated to changing people’s lives, Gold River is a groundbreaking company aiming at improving quality of life and longevity. Our diverse products and interests include nutraceuticals, CBD, land, education and more. With a unique staff of talented physicians, cultivators, and CBD experts, we are poised to tackle different disease states at an unprecedented level. Utilizing years of experience in herbals, rare cannabinoids, traditional and non-traditional methods of patient care, we are in the unique position to utilize CBD and herbals in the most effective ways possible. Emphasis on what already works, then augmenting effective formulas with high-quality cannabinoids in therapeutic levels, can achieve unprecedented symptom control in a myriad of disease states.

Stock Info
Pink Current / Verified Profile
1,300,000,000 Authorized
1,266,089,842 Outstanding Shares (Restricted: 211,198,093 / Unrestricted 1,054,891,749)
OTC disclosures & Financials: https://www.otcmarkets.com/stock/GRPS/disclosure
2nd QTR should be posted 8-15

On 2/28/21, the company updated its articles to include this note regarding toxic debt and no reverse stock split:

“The Corporation shall not issue any convertible promissory notes, convertible preferred stock or
other convertible instruments. The Corporation shall not engage in a reverse stock split.”
Articles of Amendment


Website: https://www.grpsinc.com/
Twitter: https://twitter.com/grpsinc
Dr. Bond's Twitter: https://twitter.com/DrBruceBond

Contact Info
Gold River Productions, Inc.
1419 Chafee Dr., Suite 3
Titusville, FL 32780
info@grpsinc.com

Company Video
https://www.youtube.com/watch?v=l5jg5Xvjf1o

Products Available for Pre-Order
https://doctorbondsgummies.com/
*please note that this is a pre-order as noted on the page..

Company Trademarks & Applications
https://uspto.report/company/Grps

Quarterly Podcast with the Slight Edge
Episode 1: https://podcastpeteslight.podbean.com/e/the-slight-edge-grps-001/
^ BTW in this podcast, they say that GRPS has plenty of cash on-hand.

https://www.grpsinc.com/grps-podcast/ - The GRPS website has a field to submit topics for them to cover in next quarter’s podcast.

Important notes from the most recent financial disclosures:
NOTE 3 - INVESTMENTS AND JOINT VENTURES
The Company uses the term inputs for the valuation of joint ventures and investments. The Company intends to hold investments for a term longer than one year. The Company’s investments are not traded regularly on open markets and the valuation can be very subjective. For the years ended December 31, 2020 and 2019, the Company viewed all investments as Level 3 investments with an ending value of $516,250 and $70,750, respectively. The values remain the same at March 31, 2021.

NOTE 10 - STRATEGIC ALLIANCES
During 2019, the Company entered into a strategic alliance with LeGanjaFairy LLC (LeGanja) and RushNet Inc. (Rush). As part of this alliance, LeGanja will be provided $5,000,000 in funding in exchange for their gross revenues from operations being assigned to an escrow account. Those gross revenues, less a variable percentage, will belong to the Company and paid out according to the agreement with LaGanja and RushNet Inc. During the year ended December 31, 2020 LaGanja failed to provide financial statements in accordance with the strategic agreement for the 3rd and 4th quarters. At this time, the Company is evaluating whether or not to continue with the agreement.

During 2020, the Company entered into a strategic alliance with Able Academics LLC (Able). As part of this alliance, Able will be provided $7,500,000 in funding in exchange for their gross revenues from operations being assigned to an escrow account. Those gross revenues, less a variable percentage, will belong to the Company and paid out according to the agreement with Able. During the three months ended March 31, 2020 those revenues totaled $868,871.

https://backend.otcmarkets.com/otcapi/company/financial-report/287288/content

Here is a Chronological Rundown of Recent Product Development News & Company Updates
**All of this information is pulled from their Twitter Feed or PRs

May 23 - Company offers a look-ahead, and notes minor issues with Shopify.
In the next few weeks we will be excited to reveal a lot of the details regarding partnerships, doctor networks, crucial affiliates. Shopify is being addressed. Many companies have Cbd policies that are difficult to navigate properly. We have hired a terrific marketing firm.

June 1 - Company asks for patience
We are entering a phase of our operations that will demand a significant amount of extra time and attention. Although our social media updates will be reduced, we appreciate your patience as we work to finalize agreements that we believe will bring great value to our organization

June 16 - Announced contract with Eden Labs for Painplex, Energyplex, & Inflammaplex
We are committed to quality, which is why we contracted with the best in the business—Eden Labs to help make PAINPLEX, ENERGYPLEX, and INFLAMMAPLEX a reality. What's unique about Eden is their ability to extract properly (ethanol extraction at specific ratios).

https://www.edenlabs.com/

June 16 - Announced contract with HoliHemp in Washington State to produce the gummies line of products
Holihemp, in WA, was contracted to make our gummies due to their broad range of applications and a reputation for using Compliant Hemp Oil Distillate. Their ability to insert large quantities of rare cannabinoids in gummies without sacrificing taste was key. They operate a stellar facility that meets state, fed, and intl regulatory standards.

https://www.holihemp.com/

June 17th - Announced their partnership with Laurelcrest CBD for CBD source
We'd like to share with you our first class source for product. LAURELCREST. They were able to institute our precise targeted formulations utilizing large amounts of specific and rare cannabinoids.

https://www.laurelcrest.com/

LAURELCREST offers us:

- Advanced Delivery Systems
- USA Grown Hemp
- Allergen-free
- Full Spectrum/Broad Spectrum
- Isolates
- Consistent High Quality
- Full Traceability
- Control from Seed to Sale
- NANO Technology
- 100% Regulatory Compliance


June 21 - New logo and announcement of a marketing team hired
Innovative products and solutions are the foundation for growth, but innovation by itself cannot sustain an organization; it must be coupled with strategic marketing. We're pleased to share that we've retained a marketing team with limitless capabilities. https://twitter.com/grpsinc/status/1406997126362578952

June 21 - Company telling us that there will be steady news, once ready...
We have mapped out a progressive release of information and will continue to reveal marketing, acquisitions and what the future holds. This will not happen all at once, and there’s a lot of information that will become clear


June 23 - Company News Release - Distribution through AllStar Health Brands to commence internationally
Gold River Productions (OTC Pink: GRPS), through its distribution partner, All Star Health Brands Inc, expects to commence distribution and sales of three of its unique-formulated supplements as well as the first set of products within its long-awaited gummy line. This distribution will expand to certain international markets within the next six months. Ongoing discussions are in place with Jamaican and US distributors. Other markets may include Canada and parts of Latin America. Also noted is a source of funding from a charity. http://epidemiologicsolutions.com/
https://www.otcmarkets.com/stock/GRPS/news/Gold-River-Productions-GRPS-announces-distribution-plans-and-finalization-of-RD-for-three-unique-formulation-supplements?id=308673

June 25 - Company provides operational updates via twitter
As our loyal shareholders know, we are very diligent in the quality of our personnel and our products. We are taking special care to ensure the best partners for distribution as well, as that’s the key to our future. This must be a solid acquisition and not done in haste.

In the last year, we have done some very remarkable things as a company:

-We have created and produced core products that are unique to the marketplace and sorely needed by customers

-We have demonstrated the unique efficacy of three of these products (our gummy line), as shown in many enthusiastic testimonials

-We have initiated 2 different distribution models with wide ranging potential and are now getting ready to deliver those products

-We have amassed a professional staff of dedicated, highly respected physicians and business people that share our enthusiasm for the company mission

-We have engaged a dedicated marketing firm that specifically sought us out because of the effect our product had on a family member

-All of this has been done so far on personal funding with no dilution. The future is ours, and we wish to thank our family of investors for their patience. With all the pieces falling into place, now the fun can really begin.

July 14 - GRPS names Dr. Danielle Morosco to the team, and creates a Pet Division.
Gold River Productions, Inc. (OTC Pink: GRPS) expands its product line into the pet space, an industry with a projected market size of $325,740,000,000 by 2028, according to Fortune Business Insights. We welcome our newest member, Dr. Danielle Morosco, to head our veterinary division. Dr. Morosco has vast experience with domestic animals, especially cats and dogs, and has enthusiastically embraced our unique formulation for pain and anxiety for house pets. Her expertise also includes treating larger animals. We are impressed with her input designing an equine and bovine formulation based on our pain formula.
Dr. Morosco graduated with honors from Ross University School of Veterinary Medicine, focusing on emergent and animal chronic care. She is currently completing a 110-hour continuing education course to become a Veterinary Botanical Medicine Consultant, which includes in depth modules about herbal treatments and CBD in veterinary patients.

“Our pet formulation appears to be the only one on the market that utilizes rare cannabinoids in addition to being affordable and effective” says Richard Goulding, M.D. “And when it comes to how pets are viewed by their owners, they are essentially people too. Their problems are more subtle and it’s often difficult to gauge when an animal is in pain. But the dogs we’ve tested with this product, we’ve seen noticeable and immediate results and a real sense of calm.”

https://www.otcmarkets.com/stock/GRPS/news/Gold-River-Productions-Inc-GRPS-Announces-its-Veterinary-Division-Headed-by-Dr-Danielle-Morosco?id=311570.

July 28 - Dr. Bruce Bond posts photos of samples of the Plex Line on twitter
Received 650-700 capsules of each product from EdenLabs Energyplex, Inflammaplex, Painplex and Echinaceaplex. Want to thank Dr. Goulding and the whole GRPS team for all that they are doing. We will be working on the next phase which is developing labeling, etc. and then go to larger production and then bottling.

https://twitter.com/DrBruceBond/status/1420488965564604422

August 4 - GRPS names Michael Berkowitz to the team, creates StemSpa Subsidiary and Rejuvenation Division
“We are in negotiations to construct stand-alone facilities in strategic locations to establish “StemSpa,” which will serve as centers of excellence in the United States and offshore. We will begin with approximately 1000 doctors thanks to the relationship built between GRPS, heliosDx, and CEO Ashley Sweat of Rushnet (OTC Pink: RSHN).
https://www.globenewswire.com/news-release/2021/08/04/2274718/0/en/Gold-River-Productions-Inc-GRPS-Appoints-Michael-Berkowitz-to-spearhead-the-Rejuvenation-Division-with-StemSpa.html

Florida SOS filing for StemSpa Document

https://twitter.com/grpsinc/status/1423665641698045955

August 9 - Gold River Productions, Inc. (GRPS) signs agreement for marketing and distribution with VirExit Technologies

https://saferplace.market/
https://saferplace.market/search?q=gummies

Gold River Productions, Inc. (OTC Pink: GRPS) announced today the finalization of a marketing and distribution agreement with Virexit Technologies.

“VirExit Technologies (OTC Pink: VXIT) is not just another marketing website,” says Richard Goulding, M.D., Chairman of the Board of Gold River Productions. “The Safer Place Market (www.saferplace.market) which is transitioning into the VMarket (www.vmarket.shop) is truly a unique concept that marries ‘word of mouth’ advertising with viral marketing. Their concept is fascinating. It enables the linking of actual consumer and business experiences to multiple internet outlets. The company’s focus on wellness, health, productivity, and safety offers real solutions for businesses and consumers.

Every product in VirExit’s stores is curated and focused directly on these four pillars. The public is inundated with ads, glitzy marketing and celebrity endorsements. Understanding what one finds online and the value of it is challenging. Finding a best of breed product, with a foundation in science and medicine, is challenging.
VirExit and Gold River Productions are achieving this level of product credibility. Announcing game-changing products, including our gummy and nutraceutical lines is both exciting and energizing. Now that research and development have been completed on Inflammaplex, Painplex and Energyplex and we’ve had a chance to sample the outstanding technical work of Eden Labs, we’re moving into mass market availability of these products.

https://www.globenewswire.com/news-release/2021/08/09/2277152/0/en/Gold-River-Productions-Inc-GRPS-signs-agreement-for-marketing-and-distribution-with-VirExit-Technologies.html

GO $GRPS!

-D

StemSpa FL business registration 8/4/21


http://search.sunbiz.org/Inquiry/CorporationSearch/SearchResultDetail?inquirytype=EntityName&directionType=Initial&searchNameOrder=STEMSPA%20P210000703990&aggregateId=domp-p21000070399-7f506c25-b4c9-424a-8229-6ef3a3800c32&searchTerm=Stemspa&listNameOrder=STEMSPA%20P210000703990


http://search.sunbiz.org/Inquiry/CorporationSearch/ConvertTiffToPDF?storagePath=COR%5C2021%5C0805%5C30116603.tif&documentNumber=P21000070399

That's understandable as well, and yes, I know, and respect you as well. You've have always brought valid information and opinions to the table. When a company direction is changed so significantly, or it is difficult to understand, its understandable that a portion of investors would become no longer interested. Best of luck to you. We have certainly been through a lot. I've made nice profits on RSHN, so I have been able to spread out a little bit, and I'm willing to let what I have left go through the gauntlet.

So then buy RSHN shares and sit back. You will get your free Helios too, and you can let them ride too. Nobody is saying you have to buy the offering or convert - those are options.

Not that complicated.

Companies go public to raise major money for expansion. The risk is becomes more on the shareholders and less on the company when it goes public.

Not to mention Goulding probably arranged it this way so that value would be given to the shareholders, hence the emphasis on HeliosDX driving value to RSHN. In essence, Goulding said hey, I have this stock with a massive following. You will easily overnight have a shareholder base of 10s of 1,000s as your shareholders. Perfect for this type of scenario. Should be a meme stock like Gamestop and AMC.

Explain what this line compares to in the proposed offering

4:49 pm - After contemplating this transaction, you return 50 of the 59 bars de candy plus the 5 free TV's you received, leaving you with 9 candy bars.

You're not returning any RSHN unless you convert. A qualified share is one held at the divy date. The offering and incentives are issued based on qualified shares, and then you may convert any of those qualified shares. You won't be asked to convert the shares before the dividend. It will be done all at once, based on qualified shares.

You're also not returning the dividend you will get, so this makes no sense.

Here's another example.......

Let’s say one buys 2,000,000 shares at .007 for a cost of $14,000 this week.

You have 2,000,000,000 shares and you know you want 1,200,000 shares to be qualified, which means you want to hold 1,200,000 shares until the ex-divy date (a qualified share). I’m saying 1.2m shares because maybe you want to convert some for Helios stock since it will be expensive to buy the 50% shares.

Just for example, for people who want to do a good trade between now and the divy date, let’s say between now and divy date, the stock goes up to .0249. You sell 800,000 shares for $19,920 cash out. Those 800k shares cost you $5,600 at .007, so the gain is $14,320. That’s a nice score for any trader - pulling out your investment, plus another $5k.

Now, possibly within the next 3 months - 6 months, the SEC registration of the offering becomes qualified (after it has been filed and much of the details are more clear for some time), and the ex-divy date is announced, you will have 1,200,000 qualified shares of RSHN.

There will be an offering period with the 1-A, this is when everyone makes their choices. Once that period is up, Helios will be set to begin trading, and RSHN share structure will be adjusted after any conversions.

Execution of the Dividend based on 1.2m RSHN Shares held...

Helios Stock Dividend
This means that you will be getting 1,500 HeliosDX shares at around $7.73/share. Value = $11,595. This is a stock dividend. It is issued based on RSHN shares owned, not converted.

HeliosDX Offering EXCLUSIVE TO RSHN HOLDERS <---this is why the media campaign, so investors come into RSHN before the dividend)
You will have the OPTION to buy up to 11 more HeliosDX shares for every 1,000 RSHN held for 50% off. That would be 13,200 x $3.87/share = $51,084. The offering would cost $51,084, but the shares would be worth $102,168.

The sweetener if RSHN shareholders participate…
You will receive 1 HeliosDx share for every 10 that you purchase in the exclusive offering. If you bought the 13,200 shares at offering, you would get 1,320 free shares more at their normal price. That’s a value of $10,203.60. So for $51,804, you’re getting the $102,168 + $10,203.60 = $112,371.60

Lets say you participate fully….
So you paid $8,400 for the 1.2m qualified RSHN shares you have left, and $51,084 for the 50% offering, so total cost is $59,484.

Your 1.2m shares are now worth $29,880 at .0249.
You have $123,966.60 in Helios DX stock (The dividend 1500 shares, the 13,200 bought at offer, and the 1,320 shares given as sweetener)

Lets look at that separated...
RSHN Cost for 1.2m shares bought: $8,400
RSHN Value for 1.2m shares held at .0249 = $29,880
Gain on RSHN = $21,480

HeliosDX Cost: $51,084
HeliosDX Value: $123,966.60
Gain on HeliosDX Divy & Offer & Sweetener: $72,162.60

Total costs: $59,484
Total Value: $153,846.60
Total Gain: $94,362.60 (158% gain)


Let’s say you just cannot afford to buy in the offering...


Helios Stock Dividend
This means that you will be getting 1,500 HeliosDX shares at around $7.73/share. Value = $11,595. This is a stock dividend. It is issued based on RSHN shares owned, not converted.

Since you cannot afford to participate in the offering, but knowing you want to keep a nice chunk of RSHN for when it moves forward as Grandeza and other subsidiaries, you decide to participate in the conversion, by converting 200,000 shares to HeliosDX shares.

Lets say the conversion will be 1 share for every 200 converted. (example only)

You will get 800 shares of HeliosDX in exchange for 200,000 RSHN.

200,000 RSHN at .0249 is valued at $4,980.
800 shares of HeliosDX at $7.73 is valued at $6,184
That is gain of $1,204 (This would be a gain of 24% - its has been stated the incentive will be at least 10%)

Now that you have turned in some RSHN you have 1,000,000 left to ride after the offering.

Your 1,000,000 shares remaining of RSHN are now worth $24,900 sitting at .0249.
You have $17,779 in Helios DX stock (The dividend 1500 shares, and the 800 you got for converting 200k RSHN.)

Lets look at that separated...
RSHN Cost for the 1m remaining shares bought .007: $7,000
RSHN Value for 1m shares remaining held at .0249 = $24,900
Gain on RSHN = $17,900

HeliosDX Cost to convert RSHN: $4,980 (200k converted x .0249 = $4,980)
HeliosDX Value: $17,779 (2300 x $7.73 = $17,779)
Gain on HeliosDX Divy & RSHN Conversion: $12,799

Total costs between RSHN & HeliosDX: $11,980
Total Value: $42,679
Total Gain: $30,699 (256% gain)

Your dividend and Helios incentives will be calculated on the qualified shares. You will THEN be able to convert any qualified RSHN.
If everyone can commit to converting some RSHN, the share structure should be reduced by up to half, which will make your RSHN shares increase (by up to 50%). Its more than likely that people will convert, so it is more likely than not that the share structure will at least be reduced some after the offering. That is why this is a split off and buy-back in one basically, and it benefits all companies, and all parties. No downside with both companies poised for growth beyond the offering.

Hope that helps. Link to Example

That’s a funny post but it’s not accurate at all.